Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz


1. Lpu8429uk5
2. 2781965-75-9
3. Refchem:1093335
4. Nurandociguatum
5. Nurandociguat [inn]
6. Nurandociguat [usan]
7. Orb2664040
8. Chembl6068024
9. Schembl24506670
10. Bay-3283142
11. Hy-159523
12. (r)-1-(1-(4-chloro-4'-(4-isobutylpiperazin-1-yl)-[1,1'-biphenyl]-2-yl)piperidin-3-yl)-5-(difluoromethyl)-1h-pyrazole-4-carboxylic Acid
13. 1-[(3r)-1-[4-chloro-4'-[4-(2-methylpropyl)-1-piperazinyl][1,1'-biphenyl]-2-yl]-3-piperidinyl]-5-(difluoromethyl)-1h-pyrazole-4-carboxylic Acid
14. 1-[(3r)-1-{4-chloro-4'-[4-(2-methylpropyl)piperazin-1-yl][1,1'-biphenyl]-2-yl}piperidin-3-yl]-5-(difluoromethyl)-1h-pyrazole-4-carboxylic Acid
15. 1h-pyrazole-4-carboxylic Acid, 1-[(3r)-1-[4-chloro-4'-[4-(2-methylpropyl)-1-piperazinyl][1,1'-biphenyl]-2-yl]-3-piperidinyl]-5-(difluoromethyl)-
| Molecular Weight | 572.1 g/mol |
|---|---|
| Molecular Formula | C30H36ClF2N5O2 |
| XLogP3 | 3.9 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 8 |
| Rotatable Bond Count | 8 |
| Exact Mass | Da |
| Monoisotopic Mass | Da |
| Topological Polar Surface Area | 64.8 |
| Heavy Atom Count | 40 |
| Formal Charge | 0 |
| Complexity | 824 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 1 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE